![Alan Moore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Alan Moore
Eerdere bekende functies van Alan Moore
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
XORTX Pharma Corp.
![]() XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Directeur/Bestuurslid | - | 29-01-2018 |
PACGEN LIFE SCIENCE CORPORATION | Directeur/Bestuurslid | 01-06-2006 | 10-01-2012 |
TRILLIUM THERAPEUTICS | Directeur/Bestuurslid | 30-09-2010 | 31-12-2010 |
President | 30-09-2010 | 31-12-2010 | |
CORREVIO PHARMA CORP. | Corporate Officer/Principal | 01-01-2002 | 01-01-2004 |
Norwich Eaton Pharmaceuticals, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-01-1982 | 01-01-1982 |
Opleiding van Alan Moore
University of Aston | Doctorate Degree |
Statistieken
Internationaal
Canada | 5 |
Verenigd Koninkrijk | 2 |
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 3 |
President | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Correvio Pharma Corp.
![]() Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Trillium Therapeutics ULC
![]() Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Pacgen Life Science Corp.
![]() Pacgen Life Science Corp. BiotechnologyHealth Technology Pacgen Life Science Corp. is a life science technology company, which engages in the development and commercialization of biomedical products and services. It specializes in the operation of global commercial platform to market and distribute consumer health products developed by small business enterprises. The company focuses on oral care and skin care commercial rights. Pacgen Life Science was founded by Fred Huang and Chung Yu Wang on April 23, 2004 and is headquartered in Vancouver, Canada. | Health Technology |
Norwich Eaton Pharmaceuticals, Inc. | |
XORTX Pharma Corp.
![]() XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Health Technology |
- Beurs
- Insiders
- Alan Moore
- Ervaring